Regulatory News
Tuesday, January 17, 2017
BRIEF-PULMATRIX DRUG CANDIDATE RECEIVES QIDP DESIGNATION FROM FDA
* PULMATRIX DRUG CANDIDATE RECEIVES "QUALIFIED INFECTIOUS
DISEASE PRODUCT" (QIDP) DESIGNATION FROM THE FDA
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment